EngerixTM-B

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Hepatitis B

Phase 2

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

CompletedNCT01777295

GlaxoSmithKlineHepatitis B

Start: 2013-02-25End: 2016-09-13Updated: 2019-01-04

Phase 3

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

CompletedNCT00880477

GlaxoSmithKlineHepatitis B

Start: 2001-01-31End: 2002-11-30Updated: 2016-09-07

Phase 4

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

CompletedNCT00774995

GlaxoSmithKlineHepatitis B

Start: 2008-11-30End: 2010-06-30Updated: 2016-11-02

Related Papers

Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine

Science Translational Medicine2024-07-3115 citations

Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults

Vaccine2022-03-303 citations

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.

2019-03-0559 citations

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers.

2012-07-0140 citations